These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2261014)

  • 1. Specific bradycardic agents. 1. Chemistry, pharmacology, and structure-activity relationships of substituted benzazepinones, a-new class of compounds exerting antiischemic properties.
    Reiffen M; Eberlein W; Müller P; Psiorz M; Noll K; Heider J; Lillie C; Kobinger W; Luger P
    J Med Chem; 1990 May; 33(5):1496-504. PubMed ID: 2261014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacological characterization of some benzazepinone derivatives.
    Budriesi R; Rampa A; Bisi A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1995 Mar; 45(3):234-9. PubMed ID: 7741775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific bradycardic agents. 2. Heteroaromatic modifications in the side chain of specific bradycardic benzazepinones: chemistry, pharmacology, and structure-activity relationships.
    Bomhard A; Reiffen M; Heider J; Psiorz M; Lillie C
    J Med Chem; 1991 Mar; 34(3):942-7. PubMed ID: 2002475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".
    Kobinger W; Lillie C
    Eur J Pharmacol; 1984 Sep; 104(1-2):9-18. PubMed ID: 6499920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the mechanism of the "specific bradycardic action" of the verapamil derivative UL-FS 49.
    Doerr T; Trautwein W
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):331-40. PubMed ID: 1692108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific bradycardic agents--a novel pharmacological class?
    Kobinger W; Lillie C
    Eur Heart J; 1987 Dec; 8 Suppl L():7-15. PubMed ID: 2897916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular hybrid drugs: new benzazepinone derivatives as bradycardic agents endowed with selective beta1-non-competitive antagonism.
    Bisi A; Rampa A; Budriesi R; Gobbi S; Belluti F; Ioan P; Valoti E; Chiarini A; Valenti P
    Bioorg Med Chem; 2003 Apr; 11(7):1353-61. PubMed ID: 12628661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cardiovascular properties of fluorenyl derivatives related to verapamil.
    Romanelli MN; Teodori E; Scapecchi S; Dei S; Budriesi R; Chiarini A
    Farmaco; 1991 Oct; 46(10):1121-38. PubMed ID: 1815578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigations differentiating the mechanism of specific bradycardic agents from that of calcium channel blockers.
    Lillie C; Kobinger W
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):331-3. PubMed ID: 3587375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological profile of some chloroxanthone-1, 4-dihydropyridine derivatives.
    Bisi A; Budriesi R; Rampa A; Fabbri G; Chiarini A; Valenti P
    Arzneimittelforschung; 1996 Sep; 46(9):848-51. PubMed ID: 8876931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5-pyridine-dicarbo xylates. 2.
    Baraldi PG; Garuti L; Leoni A; Cacciari B; Budriesi R; Chiarini A
    Drug Des Discov; 1993; 10(4):319-29. PubMed ID: 8148471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry, pharmacology, and structure-activity relationships with a new type of imidazolines exerting a specific bradycardic action at a cardiac site.
    Stähle H; Daniel H; Kobinger W; Lillie C; Pichler L
    J Med Chem; 1980 Nov; 23(11):1217-22. PubMed ID: 7452671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorenone and benzophenone 1,4-dihydropyridine derivatives with cardiodepressant activity.
    Rampa A; Budriesi R; Bisi A; Chiarini A; Valenti P
    Arzneimittelforschung; 1992 Nov; 42(11):1284-7. PubMed ID: 1492840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A summary of the acute effects of falipamil in man.
    Gülker H
    Eur Heart J; 1987 Dec; 8 Suppl L():141-6. PubMed ID: 3330525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinus tachyarrhythmias and the specific bradycardic agents: a marriage made in heaven?
    Yusuf S; Camm AJ
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):89-105. PubMed ID: 12808482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAR studies in the field of calcium(II) antagonists. Effect of modifications at the tetrasubstituted carbon of verapamil-like compounds.
    Gualtieri F; Teodori E; Bellucci C; Pesce E; Piacenza G
    J Med Chem; 1985 Nov; 28(11):1621-8. PubMed ID: 4067990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological influence of specific bradycardic agents on the pacemaker current of sheep cardiac Purkinje fibres. A comparison between three different molecules.
    Van Bogaert PP; Goethals M
    Eur Heart J; 1987 Dec; 8 Suppl L():35-42. PubMed ID: 3451881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations into the bradycardic effects of UL-FS 49 (1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on-hydrochloride) in isolated guinea pig atria.
    Lillie C; Kobinger W
    J Cardiovasc Pharmacol; 1986; 8(4):791-7. PubMed ID: 2427820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones.
    Floyd DM; Kimball SD; Krapcho J; Das J; Turk CF; Moquin RV; Lago MW; Duff KJ; Lee VG; White RE
    J Med Chem; 1992 Feb; 35(4):756-72. PubMed ID: 1542102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cardiovascular properties of furazanyl-1,4-dihydropyridines and of furoxanyl analogues.
    Gasco AM; Fruttero R; Sorba G; Gasco A; Budriesi R; Chiarini A
    Arzneimittelforschung; 1992 Jul; 42(7):921-5. PubMed ID: 1418057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.